These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22577940)
1. Resistin in idiopathic inflammatory myopathies. Filková M; Hulejová H; Kuncová K; Pleštilová L; Cerezo LA; Mann H; Klein M; Zámečník J; Gay S; Vencovský J; Senolt L Arthritis Res Ther; 2012 May; 14(3):R111. PubMed ID: 22577940 [TBL] [Abstract][Full Text] [Related]
2. The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies. Pleštilová L; Mann H; Andrés Cerezo L; Pecha O; Vencovský J; Šenolt L Arthritis Res Ther; 2014 Oct; 16(5):468. PubMed ID: 25359220 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 in idiopathic inflammatory myopathies. Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920 [TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. Andrés Cerezo L; Hulejová H; Šumová B; Kropáčková T; Kryštůfková O; Klein M; Mann HF; Zámečník J; Pecha O; Pavelka K; Vencovský J; Šenolt L Cytokine; 2019 Apr; 116():13-20. PubMed ID: 30684913 [TBL] [Abstract][Full Text] [Related]
5. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies. Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698 [TBL] [Abstract][Full Text] [Related]
6. The role of resistin in inflammatory myopathies. Filková M; Senolt L; Vencovský J Curr Rheumatol Rep; 2013 Jun; 15(6):336. PubMed ID: 23591826 [TBL] [Abstract][Full Text] [Related]
8. Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients. Hulejová H; Kryštůfková O; Mann H; Klein M; Pavlíčková K; Zámečník J; Vencovský J; Šenolt L Clin Exp Rheumatol; 2016; 34(2):222-9. PubMed ID: 26886056 [TBL] [Abstract][Full Text] [Related]
9. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431 [TBL] [Abstract][Full Text] [Related]
10. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies. Notarnicola A; Lapadula G; Natuzzi D; Iannone F Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956 [TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284 [TBL] [Abstract][Full Text] [Related]
12. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies. Ge Y; Lu X; Peng Q; Shu X; Wang G PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687 [TBL] [Abstract][Full Text] [Related]
14. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis. Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600 [TBL] [Abstract][Full Text] [Related]
15. Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile. Kropáčková T; Vernerová L; Štorkánová H; Horváthová V; Vokurková M; Klein M; Oreská S; Špiritović M; Heřmánková B; Kubínová K; Cerezo LA; Kryštůfková O; Mann H; Ukropec J; Ukropcová B; Zámečník J; Tomčík M; Vencovský J; Šenolt L Clin Exp Rheumatol; 2021; 39(5):1021-1032. PubMed ID: 33124569 [TBL] [Abstract][Full Text] [Related]
16. Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy. Yu Z; Cheng H; Liang Y; Ding T; Yan C; Gao C; Wen H Front Immunol; 2021; 12():642070. PubMed ID: 33936057 [TBL] [Abstract][Full Text] [Related]
18. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Liprandi A; Bartoli C; Figarella-Branger D; Pellissier JF; Lepidi H Acta Neuropathol; 1999 Jun; 97(6):642-8. PubMed ID: 10378384 [TBL] [Abstract][Full Text] [Related]
19. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
20. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies]. Zu N; Wang GC Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1157-60. PubMed ID: 21756766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]